title: Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine.
authors: Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
authors: M K
authors: MK
authors: Tsai
authors: M Y
authors: MY
authors: Lai
authors: R H
authors: RH
authors: Hu
authors: C J
authors: CJ
authors: Lee
authors: P H
authors: PH
authors: Lee
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002353:Carrier State; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology*; D006513:Hepatitis B e Antigens / Q000097:blood; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000821:virology; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D007166:Immunosuppressive Agents; D019259:Lamivudine